45
Participants
Start Date
January 18, 2024
Primary Completion Date
May 14, 2024
Study Completion Date
May 22, 2024
Itraconazole
itraconazole 200 mg QD Days 6 to 16
rifampicin
rifampicin 600 mg QD Days 6 to 20
Ecopipam
89.6 mg on Days 1 and 9 for Part 1 or 179.2 mg on Days 1 and 13 for Part 2
Syneos Health Clinic Inc., Québec
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
Cambridge Cognition Ltd
INDUSTRY
Emalex Biosciences Inc.
INDUSTRY